Kaushik, Abhinav
Dunham, Diane
Han, Xiaorui http://orcid.org/0000-0002-9058-3363
Do, Evan
Andorf, Sandra http://orcid.org/0000-0002-3093-2568
Gupta, Sheena
Fernandes, Andrea http://orcid.org/0000-0002-2855-4262
Kost, Laurie Elizabeth
Sindher, Sayantani B.
Yu, Wong
Tsai, Mindy
Tibshirani, Robert
Boyd, Scott D. http://orcid.org/0000-0003-0963-044X
Desai, Manisha
Maecker, Holden T.
Galli, Stephen J. http://orcid.org/0000-0001-5736-5340
Chinthrajah, R. Sharon http://orcid.org/0000-0003-2467-4256
DeKruyff, Rosemarie H.
Manohar, Monali http://orcid.org/0000-0002-1869-2645
Nadeau, Kari C. http://orcid.org/0000-0002-2146-2955
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI104209, U01 AI140498, R01AI140134)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
The Sean N. Parker Center for Allergy and Asthma Research at Stanford University
Article History
Received: 2 November 2021
Accepted: 19 October 2022
First Online: 4 November 2022
Competing interests
: K.C.N. reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS), and Food Allergy Research & Education (FARE); stock options from IgGenix, Seed Health, ClostraBio, and ImmuneID; is a Director of World Allergy Organization (WAO), Advisor at Cour Pharma, Consultant for Excellergy, Red tree ventures, Eli Lilly, and Phylaxis, Co-founder of Before Brands, Alladapt, Latitude, and IgGenix; and National Scientific Committee member at Immune Tolerance Network (ITN), and National Institutes of Health (NIH) clinical research centers, outside the submitted work; patents include, “Mixed allergen composition and methods for using the same”, “Granulocyte-based methods for detecting and monitoring immune system disorders”, “Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders,” and “Methods of isolating allergen-specific antibodies from humans and uses thereof”. R.S.C. reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, Stanford Maternal and Child Health Research Institute (MCHRI), and FARE. She is an Advisory Board Member at Alladapt Therapeutics, Novartis, Genentech, Sanofi, Allergenis, and Nutricia. S.B.S. reports grants from NIH, Regeneron, DBV, AIMMUNE, Novartis, CoFAR, and FARE. She receives personal fees from Astra Zeneca, DBV, and honoraria from FARE. S.J.G. reports grants from the NIH. S.D.B. has consulted for Regeneron, Sanofi and Novartis on topics unrelated to this study, owns shares in AbCellera, has patents awarded or submitted related to immunoglobulin gene and protein analysis, and reports grants from the NIH. S.A. reports grants from the NIH. All others authors declare no competing interests.